pyrimidine has been researched along with Central Nervous System Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abeling, NG; Assmann, B; Beke, E; Busch, R; Hoffmann, GF; Kulik, W; Lorente, I; Mayatepek, E; Meinsma, R; Ribes, A; Rutsch, F; Stroomer, AE; van Cruchten, A; van Gennip, AH; van Kuilenburg, AB; van Lenthe, H; Voit, T; Wevers, RA; Zoetekouw, L | 1 |
| Connolly, GP | 1 |
2 other study(ies) available for pyrimidine and Central Nervous System Disease
| Article | Year |
|---|---|
beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.
Topics: Amidohydrolases; Aminoisobutyric Acids; beta-Alanine; Central Nervous System Diseases; Female; Humans; Infant; Liver; Male; Mutation; Oxidative Stress; Purine-Pyrimidine Metabolism, Inborn Errors; Pyrimidines | 2004 |
Abnormal pyrimidine metabolism is the basis of some neurological diseases.
Topics: Autistic Disorder; Central Nervous System Diseases; Humans; Intellectual Disability; Pyrimidines; Seizures | 1998 |